Clinical Trials for Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma

Find clinical trials for transformed indolent b-cell non-hodgkin lymphoma to diffuse large b-cell lymphoma. Discover research opportunities and treatment options in your area.

4 Active Trials Found

Showing 4 trials on this page

Page 1 of 1

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT06015880

This clinical trial is testing a combination of three anti-cancer drugs—mosunetuzumab, polatuzumab vedotin, and lenalidomide—to see how well they work together for patients with a type of blood can...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Oklahoma City, Oklahoma, United States +6 more

NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

NCT ID: NCT05359211

This clinical trial is looking at a new treatment approach for patients with certain types of large B-cell lymphoma, a form of blood cancer that has either come back after treatment or has not resp...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

Tegavivint for Treating Patients with Relapsed or Refractory Large B-Cell Lymphoma

NCT ID: NCT05755087

This clinical trial is studying a new treatment called tegavivint for patients with certain types of large B-cell lymphomas that have come back after treatment or have not responded to previous the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

NCT ID: NCT06238648

This clinical trial is studying a new treatment called epcoritamab for patients with specific types of B-cell lymphoma who did not fully recover after receiving a type of therapy known as CAR-T. Ep...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hackensack, New Jersey, United States, New York, New York, United States +4 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions